Loading clinical trials...
Loading clinical trials...
A Phase II Study of Docetaxel Before Medical Castration With Degarelix in Patients With Newly Diagnosed Metastatic Prostatic Adenocarcinoma.
Conditions
Interventions
Docetaxel
Degarelix
Locations
1
United States
Medical University of South Carolina
Charleston, South Carolina, United States
Start Date
March 1, 2017
Primary Completion Date
March 3, 2021
Completion Date
December 11, 2024
Last Updated
October 15, 2025
NCT04090775
NCT02458716
Lead Sponsor
Medical University of South Carolina
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions